News

October 18, 2007 - Vascular Solution Inc. spotlights its Guardian hemostasis valve and Gopher Support Catheter at TCT ...

Home October 17, 2007
Home
News

October 18, 2007 - Boston Scientific Corp. today announced it will restructure or sell several business units to reduce operating expenses by 13 percent in 2008 in a move designed to enhance short- and long-term shareholder value.

Home October 17, 2007
Home
News

October 18, 2007 - This year at TCT ProSolv CardioVascular, a FUJIFILM company and leading provider of enterprise-level ...

Home October 17, 2007
Home
28475_3
Feature | Melissa Allen

During the last several decades, the prevalence of Methicillin-Resistant Staphylococus Aureus (MRSA) and other ...

Home October 17, 2007
Home
News

October 18, 2007 - Guerbet will feature at TCT 2007 its x-ray contrast agent, Oxilan (ioxilan) injection, a contrast ...

Home October 17, 2007
Home
News

October 18, 2007 – XTENT Inc. announced that two-year data from the CUSTOM I trial and 1-year data from the CUSTOM II ...

Home October 17, 2007
Home
News

October 18, 2007 - Combining all of the features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi ...

Home October 17, 2007
Home
News

October 18, 2007 - Toshiba America Medical Systems Inc. is showcasing its suite of workflow and storage enhancements for ...

Home October 17, 2007
Home
News

October 18, 2007 - At TCT 2007, Philips Medical Systems is presenting two live interventional cases with the University ...

Home October 17, 2007
Home
28476_1
Feature | Cristen C. Bolan

Ever since the BASKET-LATE study came out suggesting an increase in the rate of death and myocardial infarction in ...

Home October 17, 2007
Home
News

October 18, 2007 - At TCT 2007, Radi Medical Systems Inc. focuses on the Femostop HD Femoral Compression System, that with the addition of a hemostatic dressing, promotes dual-action hemostasis, reportedly reducing the need for stocking multiple hemostasis products.

Home October 17, 2007
Home
News

October 18, 2007 - Cordis Corp. will present clinical data backing the CYPHER Sirolimus-eluting coronary stent at the ...

Home October 17, 2007
Home
News

October 18, 2007 - Abbott announced that trial results for ABSORB, the world’s first clinical trial evaluating the safety and performance of a fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease, are positive.

Home October 17, 2007
Home
News

October 17, 2007 - Boston Scientific Corp. will be presenting safety and efficacy data on its TAXUS Express2 and TAXUS ...

Home October 16, 2007
Home
Technology

The FDA gave ZOLL Medical Corp., a manufacturer of resuscitation devices and related software solutions, clearance to market and sell the ZOLL AED Pro with See-Thru CPR technology, which is designed to help minimize interruptions in CPR. ZOLL aims to comply with a key recommendation of the American Heart Association’s Guidelines for Advanced Cardiac Life Support.

Home October 16, 2007
Home
Subscribe Now